tiprankstipranks
Trending News
More News >

RAMM Pharma Cancels Planned Private Placement

RAMM Pharma Cancels Planned Private Placement

Ramm Pharma Corp (TSE:RAMM) has released an update.

Confident Investing Starts Here:

RAMM Pharma Corp., a leader in cannabinoid pharmacology, has cancelled its previously announced private placement after withdrawing its appeal against the Canadian Securities Exchange’s decision which required shareholder approval. The company, with international production and sales in pharmaceuticals and hemp-based products, will communicate future financing plans at a later date. This strategic shift comes despite RAMM’s robust product pipeline and established market presence in Latin America and Europe.

For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1